Mervaala, E <br/><br/>
Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes.  [electronic resource] 

 -  Hypertension (Dallas, Tex. : 1979)  Jan 2000 
 - 360-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0194-911X 
<br/><br/><label>Standard No.: </label>10.1161/01.hyp.35.1.360  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Albuminuria--chemically induced<br/>Angiotensin II--adverse effects<br/>Angiotensinogen--genetics<br/>Animals<br/>Animals, Genetically Modified<br/>Blood Pressure<br/>Cyclosporine--pharmacology<br/>Enzyme Inhibitors--pharmacology<br/>Gene Expression Regulation, Enzymologic--drug effects<br/>Heart Diseases--chemically induced<br/>Humans<br/>Hypertension, Renal--chemically induced<br/>Interleukin-6--genetics<br/>Kidney--cytology<br/>Male<br/>Monocytes--cytology<br/>Myocardium--cytology<br/>NF-kappa B--metabolism<br/>Neutrophils--cytology<br/>Nitric Oxide--metabolism<br/>Nitric Oxide Synthase--genetics<br/>Nitric Oxide Synthase Type II<br/>Protein Binding--drug effects<br/>Rats<br/>Renin--genetics